ADDRESS-2 is now supporting a study to understand better how much insulin people with type 1 diabetes can make within the first year of diagnosis.
Recruiting to 31st December 2017
At the time of diagnosis with type 1 diabetes most people still make some of their own insulin. We can assess the body’s ability to make insulin by measuring C-peptide. The aims of ADDRESS C-Peptide are:
- To understand better how much insulin people with type 1 diabetes can make within the first year of diagnosis and how it varies with other characteristics of type 1 diabetes.
- To find out whether measurement of C-peptide in urine samples collected at home is a valid and practical way to assess insulin production in the first year following diagnosis.
Eligibility to take part
1. Participant in ADDRESS-2 (aged 5 or older)
2. Diagnosed with type 1 diabetes within the last 3-12 months
What will I/my child be asked to do?
You/your child will be asked to collect urine samples at home and complete a questionnaire at 2 or 3 time points within the first year of having type 1 diabetes.
We will invite 29 adults to attend a 3-hour study appointment for additional blood tests.
Who is running this study?
This study is being run by the same research team that runs ADDRESS-2 at Imperial College London and Imperial College Healthcare NHS Trust. The Chief investigator is Prof Des Johnston.
It is funded by Diabetes UK and the Juvenile Diabetes Research Foundation.
For participants invited to attend a study appointment, this will take place at one of the hospitals listed below.
Study visit locations
St Mary’s Hospital, London
Hammersmith Hospital, London
Call: 020 7594 5960, Miss Akaal Kaur, Study Coordinator
Read about other studies we are supporting.